"Bioterrorism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of biological agents in TERRORISM. This includes the malevolent use of BACTERIA; VIRUSES; or other BIOLOGICAL TOXINS against people, ANIMALS; or PLANTS.
| Descriptor ID |
D023482
|
| MeSH Number(s) |
I01.198.240.856.800.100 I01.880.735.900.800.100 I01.880.735.950.500.226.100
|
| Concept/Terms |
Bioterrorism- Bioterrorism
- Biological Terrorism
- Terrorism, Biological
|
Below are MeSH descriptors whose meaning is more general than "Bioterrorism".
Below are MeSH descriptors whose meaning is more specific than "Bioterrorism".
This graph shows the total number of publications written about "Bioterrorism" by people in this website by year, and whether "Bioterrorism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 4 | 0 | 4 |
| 2003 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bioterrorism" by people in Profiles.
-
Anderson PD, Bokor G. Bioterrorism: pathogens as weapons. J Pharm Pract. 2012 Oct; 25(5):521-9.
-
Artenstein AW, Grabenstein JD. Smallpox vaccines for biodefense: need and feasibility. Expert Rev Vaccines. 2008 Oct; 7(8):1225-37.
-
Summerhill EM, Mathew MC, Stipho S, Artenstein AW, Jagminas L, Russo-Magno PM, Potter S, Shapiro MJ. A simulation-based biodefense and disaster preparedness curriculum for internal medicine residents. Med Teach. 2008; 30(6):e145-51.
-
Kotwal GJ. Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). Vaccine. 2008 Jun 06; 26(24):3055-8.
-
Moye PK, Pesik N, Terndrup T, Roe J, Weissman N, Kiefe C, Houston TK. Bioterrorism training in U.S. emergency medicine residencies: has it changed since 9/11? Acad Emerg Med. 2007 Mar; 14(3):221-7.
-
Klempner M. Interview with Mark Klempner, MD, principal investigator, National Emerging Infectious Diseases Laboratories, and associate provost for research, Boston University School of Medicine. Biosecur Bioterror. 2006; 4(2):107-12.
-
Guharoy R, Panzik R, Noviasky JA, Krenzelok EP, Blair DC. Smallpox: clinical features, prevention, and management. Ann Pharmacother. 2004 Mar; 38(3):440-7.
-
Weltzin R, Liu J, Pugachev KV, Myers GA, Coughlin B, Blum PS, Nichols R, Johnson C, Cruz J, Kennedy JS, Ennis FA, Monath TP. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med. 2003 Sep; 9(9):1125-30.
-
Artenstein AW. Biodefense: medicine in the time of bioterrorism. Med Health R I. 2003 Jul; 86(7):201-3.
-
Kournikakis B, Mandeville R, Brousseau P, Ostroff G. Anthrax-protective effects of yeast beta 1,3 glucans. MedGenMed. 2003 Mar 21; 5(1):1.